Breast Cancer
Epirubicin, vinorelbine, and cisplatin are effective in advanced breast cancer
Published in Women's Health Weekly, April 8th, 2004
"Our objective was to evaluate the activity and safety of the combination of cisplatin, epirubicin and vinorelbine (CEV) in advanced breast cancer patients. Patients with advanced breast cancer, locally advanced or metastatic, received epirubicin 75 mg/m2 and cisplatin 50 mg/m2 on day 1, and vinorelbine 25 mg/m2 on day 5. Cycles were repeated every 3 weeks," investigators in Italy report.
"A total of 35 patients were treated. Thirty-one patients were evaluated for response. One hundred...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Hormone Replacement Therapy
Fewer, but more advanced, colon cancers occur in postmenopausal women on HRT - Toxicology
Lead and cadmium cancel each other out in perinatal study models - Breast Cancer
Patients unhappy with follow-up visits to oncologists - Genomics & Genetics
Sex chromosomes are influential even before gonadal hormones kick in - Obstetrics
Factor V gene polymorphisms leave Finnish women vulnerable to preeclampsia - Prognostics
Blood pressure may predict recurrent cardiovascular events in women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
